Challenges to the Sustainability of the U.S. Public Cord Blood System

Challenges to the Sustainability of the U.S. Public Cord Blood System - Research Report

Paperback (27 Oct 2017)

Not available for sale

Includes delivery to the United States

Out of stock

This service is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Publisher's Synopsis

Hematopoietic stem cells (HSCs)--from bone marrow, peripheral blood, or umbilical cord blood--are used to treat patients with cancers such as leukemia or lymphoma, disorders of the blood and immune systems, severe aplastic anemia, sickle cell disease, and certain inherited metabolic diseases. In addition to cord blood's direct therapeutic value to patients, it is also used for basic research on blood, blood stem cells, and immune cells. In recent years, the U.S. government (through the Health Resources and Services Administration) has endeavored to increase the overall national inventory--which currently contains over 200,000 units--as well as the number of high-quality units and the number of units from racial/ethnic minorities. Despite the important clinical and research roles of cord blood products and a clear public health need for increasing and diversifying our national inventory, little is systematically known about the economics

Book information

ISBN: 9781977400000
Publisher: Rand Health
Imprint: Rand Health
Pub date:
DEWEY: 615.39
DEWEY edition: 23
Language: English
Weight: 444g
Height: 280mm
Width: 213mm
Spine width: 14mm